PDS Biotechnology Corporation
PDSB
$1.26
$0.021.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 25.86% | -28.80% | 21.46% | 2.70% | -0.45% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 4.86% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -2.39% | 7.51% | 5.03% | 3.88% | 64.20% |
| Total Other Non-Cash Items | -7.54% | -13.79% | 26.55% | -7.70% | -16.46% |
| Change in Net Operating Assets | -456.33% | 121.73% | -131.44% | -411.80% | -71.10% |
| Cash from Operations | -2.93% | 9.69% | 10.87% | -17.51% | -17.86% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -22,165.25% | -2.17% | -2.22% | -2.27% | -2.33% |
| Issuance of Common Stock | 10,482.11% | -- | -100.00% | 85.77% | 1,222.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 904.65% | 224.64% | -100.07% | 85.88% | 1,241.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -0.99% | 10.32% | -188.35% | 336.27% | 136.23% |